Preparation, Characterisation and Biodistribution of ^99mTc-labeled Liposome Encapsulated Cyclosporine

References

• Adler, M., Jill, P.E., Williams, A., (1997) “Pharmaceutical formulation and process”, U.S.Patent. # 5,688,525.
   Google Scholar
• Aoki, H., Sun, C., Fuji, K. and Miyajima, K. (1995) “Disposition kinetics of liposomes modified with synthetic aminoglycolipids in rats”, Int. J. Pharm. 115, 183–191.
   Google Scholar
• Aoki, H., Tottori, T., Sakurai, F., Fuji, K. and Miyajima, K. (1997) “Effect of positive charge density on the liposomal surface on the disposition kinetics of liposomes in rats”, Int. J. Pharm. 156, 163–174.
   Web of Science ®Google Scholar
• Borel, J.F. (1988) “Immunosuppression: building on Sandimmune (Cyclosporine)”, Transplant. Proc. 20, 149–153.
   PubMed Web of Science ®Google Scholar
• Caride, V.J. (1990) “Technical and biological considerations on the use of radiolabeled liposomes for diagnostic imaging”, Nucl. Med. Biol. 17, 35–39.
   Web of Science ®Google Scholar
• Crowe, J.H., Crowe, L.M. and Carpenter, J.K. (1988) “Interactions of sugars with membranes”, Biochim. Biophys. Acta 947, 367–384.
   PubMed Web of Science ®Google Scholar
• Damen, J., Regts, J. and Scherphof, G. (1981) “Transfer and exchange of phospholipids between small unilamellar liposomes and rat plasma high density lipoproteins. Dependence on cholesterol content and phospholipid composition”, Biochim. Biophys. Acta 665, 538–542.
   PubMed Web of Science ®Google Scholar
• Dowling, R.D., Zenati, M. and Burckart, G.J. (1990) “Aerosolized cyclosporine as single agent immunotherapy in canine lung allografts”, Surgery 108, 198–199.
   PubMed Web of Science ®Google Scholar
• Gregoriadis, G.N. (1976) “The carrier potential of liposomes in biology and medicine”, N. Engl. J. Med. 295, 704–705.
   PubMed Web of Science ®Google Scholar
• Gregoriadis, G. and Neerunjun, D.E. (1974) “Control of the rate of hepatic uptake and catabolism of liposome-entrapped proteins injected into rats: possible therapeutic applications”, Eur. J. Biochem. 47, 179–185.
   PubMedGoogle Scholar
• Gregoriadis, G., Kirby, C. and Senior, J. (1983) “Optimization of liposomal behaviour in vivo”, Biol. Cell. 47, 11–18.
   Google Scholar
• Hardy, J.G., Kellway, I.W. and Rogers, H. (1980) “The distribution and fate of I-131 labeled liposomes”, J. Pharm. Pharmacol. 32, 309–313.
   PubMed Web of Science ®Google Scholar
• Kao, Y.J. and Juliano, R.L. (1981) “Interactions of liposomes with reticuloendothelial system: effects of RE-blockade on the clearance of large unilamellar vesicles”, Biochim. Biophys. Acta 677, 453–461.
   PubMed Web of Science ®Google Scholar
• Kirby, C., Clarke, J. and Gregoriadis, G. (1980) “Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro”, Biochem. J. 186, 591–592.
   PubMed Web of Science ®Google Scholar
• Klibanov, A.L., Maruyama, K., Beckerleg, A.M., Torchilin, V.P. and Huang, L. (1991) “Activity of amphipathic poly (ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavourable for immunoliposome binding to target”, Biochim. Biophys. Acta 1062, 142–148.
   PubMed Web of Science ®Google Scholar
• Lopez-Berestein, G., Hopfer, R.L., Mehta, R., Mehta, R., Hersh, E.M. and Juliano, R.L. (1984) “Liposome encapsulated amphotericin-B for treatment of disseminated candidiasis in neutropenic mice”, J. Infect. Dis. 150, 278–283.
   PubMed Web of Science ®Google Scholar
• Luke, D.R., Kasiske, B.L., Matzke, G.R. and Keane, W.F. (1987) “Effects of cyclosporine on the isolated perfused rat kidney”, Transplantation 43, 795–799.
   PubMed Web of Science ®Google Scholar
• Morgan, J.R., Williams, K.E. and Davis, R.I. (1981) “Localisation of experimental staphylococcal abscesses by 99mTc-labeled liposomes”, J. Med. Micro. 14, 213–217.
   PubMed Web of Science ®Google Scholar
• Morgan, J.R., Williams, L.A. and Howard, C.B. (1985) “Technetium- labeled liposome imaging for deep-seated infection”, Br. J. Radiol. 58, 35–38.
   PubMed Web of Science ®Google Scholar
• Nabar, S.J. and Nadkarni, G.D. (1998) “Effect of size and charge of liposomes on biodistribution of encapsulated 99mTc-DTPa in rats”, Ind. J. Pharmacol. 30, 199–202.
   Google Scholar
• Nacucchio, M.C., Gatto Bellora, M.J., Sordelli, D.O. and D’Aquino, M. (1985) “Enhanced liposome mediated activity of piperacillin against staphylococci”, Antimicrob. Agents Chemother. 27, 137–139.
   PubMed Web of Science ®Google Scholar
• Ogihara, I. and Kojimi, S. (1989) “Cholesterol enhances the delivery of liposome encapsulated gallium-67 to tumors”, Eur. J. Nucl. Med. 15, 612–619.
   PubMedGoogle Scholar
• Ogihara, I., Kojimi, S. and Jay, M. (1986) “Differential uptake of gallium- 67 labeled liposomes between tumors and inflammatory lesions in rats”, J. Nucl. Med. 27, 1300–1302.
   PubMed Web of Science ®Google Scholar
• Ostro, M.J. and Cullis, P.R. (1989) “Use of liposomes as injectable drug delivery systems”, Am. J. Hosp. Pharm. 46, 1576–1577.
   PubMedGoogle Scholar
• Perico, N. and Remuzzi, G. (1997) “Prevention of transplant rejection: current treatment guidelines and future developments”, Drugs 54, 533–570.
   PubMed Web of Science ®Google Scholar
• Puschett, J.B., Greenbery, A., Holley, J. and McCauley, J. (1990) “The spectrum of cyclosporine nephrotoxicity”, Am. J. Nephrol. 10, 296–299.
   PubMed Web of Science ®Google Scholar
• Richardson, V.J., Jeyasingh, K. and Jewkes, R.F. (1977) “Properties of [99mTc] technetium labeled liposomes in normal and tumor bearing rats”, Biochem. Soc. Trans. 5, 290–291.
   PubMed Web of Science ®Google Scholar
• Richardson, V.J., Jeyasingh, K., Jewkes, R.F., Ryman, B.E. and Tattersall, M.H. (1978) “Possible tumor localization of 99m Technetium labeled liposomes: effects of lipid composition, charge, and liposome size”, J. Nucl. Med. 19, 1049–1054.
   PubMed Web of Science ®Google Scholar
• Rudolph, A.S. (1988) “The freeze-dried preservation of liposome encapsulated hemoglobin: a potential blood substitute”, Cryobiology 25, 277–284.
   PubMed Web of Science ®Google Scholar
• Saha, G.B. (1993) “Methods of Radiolabeling”, In: Saha, G.B., ed, Physics and Radiobiology of Nuclear Medicine (Springer, New York), pp 100–106.
   Google Scholar
• Stuhne-Sekalec, L. and Stanaav, N.Z. (1991) “Liposomes as carriers of Cyclosporine A”, J. Microencapsul. 18, 441–446.
   Google Scholar
• Theobald, A.E. (1990) Chapter 7, In: Sampson, C.B., ed, Textbook of Radiopharmacy: Theory and Practice (Gordon and Breach, New York), pp 127–129.
   Google Scholar
• Thiel, G., Mihatsch, M.J., Stahl, R.A., Hermle, M. and Brunner, F.P. (1986) “Cyclosporine nephrotoxicity in Goldblatt renovascular hypertension in rats”, Clin. Nephrol. 25, S199–S204.
   PubMed Web of Science ®Google Scholar
• Treat, J., Greenspan, A. and Forst, D. (1990) “Antitumor activity of liposome encapsulated doxorubicin in advanced breast cancer: phase II study”, J. Natl Cancer Inst. 82, 1706–1710.
   PubMed Web of Science ®Google Scholar
• Vadiei, K., Perez-Soler, R., Lopez-Berestein, G. and Luke, D.R. (1989) “Pharmacokinetic and pharmacodynamic evaluation of liposomal cyclosporine”, Int. J. Pharm. 57, 125–131.
   Web of Science ®Google Scholar
• Venkataramanan, R., Habucky, K., Burckart, G.J. and Ptachcinski, R.J. (1989) “Clinical pharmacokinetics in organ transplant patients”, Clin. Pharm. 16, 134–161.
   Google Scholar
• Wu, M.S., Robbins, J.C., Ponpipom, M.M. and Shen, T.V. (1981) “Modified in vivo behaviour of liposomes containing synthetic glycolipids”, Biochim. Biophys. Acta 674, 19–29.
   PubMed Web of Science ®Google Scholar